by In2Pharma | Nov 24, 2025 | News
The Netherlands KOAGKAG has provided more clarity on the use of ‘probiotics’ on foods, based on the European legislation. Under EU Regulation (EC) No. 1924/2006, health claims are only permitted if they are scientifically substantiated and approved by the European...
by In2Pharma | Nov 19, 2025 | News
The Netherlands KOAG KAG has provided additional guidance on the use of ‘absolute’ claims in order to avoid being misleading. This includes claims that state ‘complete’, ‘from A to Z’, ‘all-in-one’ etc. They also provided a table with vitamins and minerals to better...
by In2Pharma | Oct 20, 2025 | News
The Netherlands Recent updates to the Dutch Medicines Act (Geneesmiddelenwet) of 8 February 2007 have been published. This Act defines the composition and responsibilities of the Medicines Evaluation Board (MEB) and regulates the licensing of manufacturers,...
by In2Pharma | Oct 13, 2025 | News
The Netherlands GMH (Gedragscode Medische Hulpmiddelen) has published the maximum hourly fees for service contracts for 2026. These hourly fees are indexed every year and are subcategorized by the education level of the health care professional. You can find the...
by In2Pharma | Oct 13, 2025 | News
The Netherlands Requests for the withdrawal of marketing authorizations and parallel import licenses for human medicines effective 31 December 2025 — the so-called “end-of-year withdrawals” — must be received by the Medicines Evaluation Board (CBG) no later than 1...
